Ignite Creation Date:
2024-05-06 @ 2:33 AM
Last Modification Date:
2024-10-26 @ 11:19 AM
Study NCT ID:
NCT02060721
Status:
COMPLETED
Last Update Posted:
2023-04-11
First Post:
2014-01-02
Brief Title:
Clinical Study to Assess the Safety Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
Sponsor:
Actelion
Organization:
Actelion
Study Overview
Official Title:
MERIT-2 Long Term Multicenter Single-arm Open-label Extension Study of the MERIT-1 Study to Assess the Safety Tolerabilty and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension CTEPH
Status:
COMPLETED
Status Verified Date:
2023-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MERIT-2
Brief Summary:
Long-term study to evaluate if macitentan is safe tolerable and efficient enough to be used for treatment of inoperable chronic thromboembolic pulmonary hypertension CTEPH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2013-003457-25 | EUDRACT_NUMBER | None | None |